Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled Trial
Authors:
- 3 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (9) , 872-879
Abstract
Background: Pediatric community-acquired pneumonia (CAP) can lead to long-term respiratory sequelae, including bronchiectasis. We determined if an extended (13–14 days) versus standard (5–6 days) antibiotic course improves long-term outcomes in children hospitalized with CAP from populations at high risk of chronic respiratory disease. Methods: We undertook a multicenter, double-blind, superiority, randomized controlled trial involving 7 Australian, New Zealand, and Malaysian hospitals. Children aged 3 months to ≤5 years hospitalized with radiographic-confirmed CAP who received 1–3 days of intravenous antibiotics, then 3 days of oral amoxicillin-clavulanate, were randomized to either extended-course (8-day oral amoxicillin-clavulanate) or standard-course (8-day oral placebo) arms. Children were reviewed at 12 and 24 months. The primary outcome was children with the composite endpoint of chronic respiratory symptoms/signs (chronic cough at 12 and 24 months; ≥1 subsequent hospitalized acute lower respiratory infection by 24 months; or persistent and/or new chest radiographic signs at 12-months) at 24-months postdischarge, analyzed by intention-to-treat, where children with incomplete follow-up were assumed to have chronic respiratory symptoms/signs (“worst-case” scenario). Results: A total of 324 children were randomized [extended-course (n = 163), standard-course (n = 161)]. For our primary outcome, chronic respiratory symptoms/signs occurred in 97/163 (60%) and 94/161 (58%) children in the extended-courses and standard-courses, respectively [relative risk (RR) = 1.02, 95% confidence interval (CI): 0.85–1.22]. Among children where all sub-composite outcomes were known, chronic respiratory symptoms/signs between groups, RR = 1.10, 95% CI: 0.69–1.76 [extended-course = 27/93 (29%) and standard-course = 24/91 (26%)]. Additional sensitivity analyses also revealed no between-group differences. Conclusion: Among children from high-risk populations hospitalized with CAP, 13–14 days of antibiotics (versus 5–6 days), did not improve long-term respiratory outcomes.Keywords
This publication has 41 references indexed in Scilit:
- Association of Radiology Findings with Etiology of Community Acquired Pneumonia among ChildrenThe Journal of Pediatrics, 2023
- Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in ChildrenJAMA Pediatrics, 2022
- Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired PneumoniaJAMA, 2021
- Short-Course Antimicrobial Therapy for Pediatric Community-Acquired PneumoniaJAMA Pediatrics, 2021
- Wheezing independently predicts viral infection in children with community‐acquired pneumoniaPediatric Pulmonology, 2019
- Chronic suppurative lung disease in a developing country: Impact on child and parentPediatric Pulmonology, 2014
- Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasisPediatric Pulmonology, 2013
- Respiratory health outcomes 1 year after admission with severe lower respiratory tract infectionPediatric Pulmonology, 2012
- Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasisPediatric Pulmonology, 2008
- Non‐CF bronchiectasis: Clinical and HRCT evaluationPediatric Pulmonology, 2003